Hims & Hers believes that is where the controversy lies. “We called on the industry and said that they need to change — and their reaction is trying to shut this ad down,” says a representative for the company. “To us, it's clear that it's not about the ad — it's about the message.”

A Super Bowl ad touting Hims & Hers Health Inc.’s copycat weight-loss drugs is getting pushback from the branded drugmakers’ lobbying group, which says it’s “misleading” and potentially violates marketing rules.

Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight loss drugs.